Adjunctive balloon postdilatation after stent deployment: Is it still necessary with drug-eluting stents?

Journal of Interventional Cardiology

Volumn 19, Issue 1, 2006, Pages 43-50

  Brodie, Bruce R ^a,b  

^a MOSES CONE HEALTH SYSTEM   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; RAPAMYCIN; THIENO[2,3 B]PYRIDINE DERIVATIVE;

BALLOON DILATATION; DRUG ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; REVIEW;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG DELIVERY SYSTEMS; HUMANS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33645323512     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2006.00103.x     Document Type: Review

References (34)

1. Moussa I Moses J Di Mario C et al. Does the specific intravascular ultrasound criteria used to optimize stent expansion have an impact on the probability of stent restenosis? Am J Cardiol 1999 83 1012 1017.
2. Russo RJ Attubato MJ Davidson CJ et al. Angiography versus intravascular ultrasound-directed stent placement: Final results from AVID. Circulation 1999 100 Suppl. 1 I234.
3. Fitzgerald PJ Oshima A Hayase M et al. Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation 2000 102 523 530.
4. Hoffmann R Mintz GS Mehran R et al. Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents. J Am Coll Cardiol 1998 31 43 49.
5. de Feyter PJ Kay P Disco C et al. Reference chart derived from post-stent implantation intravascular ultrasound predictors of six month expected restenosis on quantitative coronary angiography. Circulation 1999 100 1777 1783.
6. Kuntz R Safian R Carrozza J et al. The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting. Circulation 1992 86 1827 1835.
7. Kasaoka S Tobis J Akiyama T et al. Angiographic and intravascular ultrasound predictors of in-stent restenosis. J Am Coll Cardiol 1998 32 1630 1635.
8. Oemrawsingh PV Mintz GS Schalij MJ et al. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: Final results of a randomized comparison with angiographic guidance (TULIP Study). Circulation 2003 107 62 67.
9. Takano Y Higgins JR Tobis JM et al. New stent delivery systems do not provide optimal stent expansion. J Am Coll Cardiol 2001 37 Suppl. A 48A.
10. Brodie BR Cooper C Jones M et al. Is adjunctive balloon post-dilatation necessary after coronary stent deployment? Final results from the POSTIT trial. Catheter Cardiovasc Interven 2003 59 184 192.
11. Johansson B Allared M Borgencrantz B et al. Standardized angiographically guided over-dilatation of stents using high pressure technique optimize results without increasing risks. J Invasive Cardiol 2002 14 227 229.
12. Cutlip DE Baim DS Kalon KL et al. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials. Circulation 2001 103 1967 1971.
13. Moussa I Di Mario C Reimers B et al. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: Frequency, predictors and clinical outcome. J Am Coll Cardiol 1997 29 6 12.
14. Hehrlein C DeVries JJ Wood TA et al. Overestimation of stent delivery balloon diameters by manufacturers' compliance tables: A quantitative coronary analysis of Duet and NIR stent implantation. Catheter Cardiovasc Interven 2001 53 474 478.
15. Costa JR Jr. Mintz GS Carlier SG et al. Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts. Am J Cardiol 2005 96 74 78.
16. Abele JE. Balloon catheters and transluminal dilatation:Technical considerations. Am J Roentgenol 1980 135 901 906.
17. Roberts DK Hassan HM Kitamura K et al. The impact of non-compliant balloon materials on balloon delivered coronary stent expansion. Circulation 2000 102 Suppl. 2 II547.
18. Morice MC Serruys PW Sousa JE et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002 346 1773 1780.
19. Moses JW Leon MB Popma JJ et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003 349 1315 1323.
20. Stone GW Ellis SG Cox DA et al. A polymer-based paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004 350 221 231.
21. Bavry AA Kumbhani DJ Helton TJ et al. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention? A meta-analysis. J Am Coll Cardiol 2005 45 941 946.
22. Iakovou I Schmidt T Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005 293 2126 2130.
23. Fujii K Carlier SG Mintz GS et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study. J Am Coll Cardiol 2005 45 995 998.
24. Downey W Brodie BR Stuckey TD et al. High risk of subacute stent thrombosis with long/multiple drug-eluting stents. Catheter Cardiovasc Interven 2005 65 C 4.
25. Lemos PA Hoye A Goedhart D et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: An evaluation from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 2004 109 1366 1370.
26. Sonoda S Morino Y Ako J et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: Serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol 2004 43 1959 1963.
27. Takebayashi H Mintz GS Carlier SG et al. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation 2004 110 3430 3434.
28. Stone GW Ellis SG Cox DA et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation 2004 109 1942 1947.
29. Lansky AJ Costa RA Mooney M et al. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. J Am Coll Cardiol 2005 45 1180 1185.
30. Kutcher MA Applegate RJ Hermiller J et al. Optimal stent implantation pressure in the drug-eluting-stent era: Observations from the TAXUS IV study. Am J Cardiol 2004 94 213E.
31. Hwang CW Wu D Edelman ER. Physiological transport forces govern drug distribution for stent-based delivery. Circulation 2001 104 600 605.
32. Cheneau E Satler LF Escolar E et al. Underexpansion of sirolimus-eluting stents: Incidence and relationship to delivery pressure. Catheter Cardiovasc Interven 2005 65 222 226.
33. Blackman DJ Porto I Shirodaria C et al. Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis. Am J Cardiol 2004 94 922 925.
34. Iakovou I Mintz GS Dangas G et al. Increased CK-MB release is a "trade-off" for optimal stent implantation: An intravascular ultrasound study. J Am Coll Cardiol 2003 42 1900 1905.